Recently, our firm won the first instance of an administrative litigation case for invalidation of an invention patent, i...
Introduction In the chemical field, it is difficult to seek invalidation of a patent claiming to have achieved unexpected...
Laws-Patent
The Need-to-Know Amendments in the New Rules for the Implementation of China’s Patent Law
  On December 21, 2023, the new Rules for the Implementation of Patent Law (hereinafter referred to as the Rules) has been approved and promulgated by the State Council, and will come into force on January 20, 2024. There are many amendments
Announcement of China National Intellectual Property Administration on the Interim Measures for Handling Relevant Issues
  In order to guarantee smooth practice of the Hague Agreement Concerning the International Registration of Industrial Designs (1999) (hereinafter referred to as the Hague Agreement) and to fulfill the urge needs of innovative subjects for exa
Announcement of China National Intellectual Property Administration on the Interim Measures for Examination related to th
  In order to guarantee smooth practice of the amended Patent Law and to fulfill the urge needs of innovative subjects for examination of partial designs and domestic right of priority to designs, CNIPA hereby releases the amended Interim Meas
Provisions of the Supreme People’s Court on Several Issues Concerning the Application of Law in the Trial of Civil Case
  On July 5, 2021, the Supreme Peoples Court released Provisions of the Supreme Peoples Court on Several Issues Concerning the Application of Law in the Trial of Civil Cases Concerning Patent Disputes Related to Drugs Applied for Registration
Announcement of National Medical Products Administration on Matters relating to the Measures for the Implementation of Ea
  Announcement of National Medical Products Administration (NMPA) on Matters relating to the Measures for the Implementation of Early Resolution Mechanisms for Drug Patent Disputes (Trial) ([2021] No.46) In order to effectively implement the
Announcement of National Medical Products Administration and China National Intellectual Property Administration on Promu
  Announcement of National Medical Products Administration and China National Intellectual Property Administration on Promulgation of the Measures for the Implementation of Early Resolution Mechanisms for Drug Patent Disputes (Trial) [2021] N
Announcement of China National Intellectual Property Administration on the Administrative Adjudication Measures for Major
  Announcement of China National Intellectual Property Administration No.426 CNIPA has formulated the Measures for Administrative Adjudication of Major Patent Infringement Disputes in accordance with the Patent Law of the Peoples Republic of
Announcement of China National Intellectual Property Administration on the Interim Measures for Examination Related to th
  The 22nd meeting of the Standing Committee of the 13th National Peoples Congress has voted on October 17, 2020 to adopt the Decision of the Standing Committee of the National Peoples Congress on Amending the Patent Law of the Peoples Republ
Provisions of the Supreme People’s Court on Several Issues Concerning the Application of Law in the Trial of Administra
  The Provisions of the Supreme Peoples Court on Several Issues Concerning the Application of Law in the Trial of Administrative Cases Involving Patent Grant and Confirmation ( I ) , adopted at the 1810th meeting of the Judicial Committee with
Comparison chart of the fourth amendment of the Chinese Patent Law (2020)
  Comparison chart between the third amendment of the Chinese Patent Law (2008) and the fourth amendment of the Chinese Patent Law (2020) approved by the 22nd meeting of the 13th session of the Standing Committee of the National Peoples Congr
About us | Contact us | Favorite | Home Page
LINKS:Beijing Wei Chixue Law Firm
©2008-2025 By Linda Liu & Partners, All Rights Reserved.